Yohei Sekino

30PUBLICATIONS
46CO-AUTHORS
Solid tumoursCancer cell biologyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Aug 08, 2026
Impact of surgical start time on clinical outcomes in urologic surgery: a single-center study of major oncologic surgeries and adrenalectomy.

|Aug 06, 2026
RIOK2 Promotes Clear Cell Renal Cell Carcinoma Progression Through Cell Cycle Regulation.

|Jul 23, 2026
External Validation of Prognostic Models for Nonmetastatic Clear Cell Renal Cell Carcinoma in a Japanese Cohort: Evaluation of Predictive Performance.

|Jul 01, 2026
Clinical and genomic characteristics of primary resistant disease to first-line immuno-oncology plus VEGFR inhibitor therapy in metastatic renal cell carcinoma.

|May 20, 2026
Prognostic Significance of Pretreatment Blood-Based Biomarkers in Penile Cancer: A Multicenter Retrospective Study in Japan.

|Feb 26, 2026
KIFC1 is Associated With Sarcomatoid Differentiation, Immune Response, and a Poor Prognosis in Clear Cell Renal Cell Carcinoma.

Yoshinori Nakano, Yohei Sekino, Go Kobayashi

Pageof 5

Frequent Collaborators

17 joint publications

Nobuyuki Hinata

13 joint publications

Kohei Kobatake

12 joint publications

Keisuke Goto

8 joint publications

Shunsuke Miyamoto